{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:10Z","timestamp":1793413510099,"version":"4.5.0"},"publisher-location":"Singapore","reference-count":44,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811020407","type":"print"},{"value":"9789811020414","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-981-10-2041-4_3","type":"book-chapter","created":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T21:51:04Z","timestamp":1476222664000},"page":"25-34","source":"Crossref","is-referenced-by-count":15,"title":["Cell Proliferation and Apoptosis in ADPKD"],"prefix":"10.1007","author":[{"given":"Eun Ji","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"issue":"5381","key":"3_CR1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281(5381):1305\u20131308","journal-title":"Science"},{"issue":"5","key":"3_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/embor.2008.29","volume":"9","author":"CX Bai","year":"2008","unstructured":"Bai CX, Giamarchi A, Rodat-Despoix L, Padilla F, Downs T, Tsiokas L, Delmas P (2008) Formation of a new receptor-operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits. EMBO Rep 9(5):472\u2013479. doi: 10.1038\/embor.2008.29","journal-title":"EMBO Rep"},{"issue":"2","key":"3_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","volume":"109","author":"AK Bhunia","year":"2002","unstructured":"Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, Xu PN, Germino FJ, Germino GG (2002) PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109(2):157\u2013168","journal-title":"Cell"},{"issue":"7121","key":"3_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature05348","volume":"444","author":"NO Bukanov","year":"2006","unstructured":"Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O (2006) Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444(7121):949\u2013952. doi: 10.1038\/nature05348","journal-title":"Nature"},{"issue":"8","key":"3_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrneph.2015.39","volume":"11","author":"FT Chebib","year":"2015","unstructured":"Chebib FT, Sussman CR, Wang X, Harris PC, Torres VE (2015) Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nat Rev Nephrol 11(8):451\u2013464. doi: 10.1038\/nrneph.2015.39","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"3_CR6","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/MCB.01259-08","volume":"29","author":"G Distefano","year":"2009","unstructured":"Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek KB, Germino GG, Pandolfi PP, Boletta A (2009) Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol Cell Biol 29(9):2359\u20132371. doi: 10.1128\/MCB.01259-08","journal-title":"Mol Cell Biol"},{"issue":"5","key":"3_CR7","first-page":"476","volume":"4","author":"Y Dobashi","year":"2011","unstructured":"Dobashi Y, Watanabe Y, Miwa C, Suzuki S, Koyama S (2011) Mammalian target of rapamycin: a central node of complex signaling cascades. Int J Clin Exp Pathol 4(5):476\u2013495","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"3_CR8","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1046\/j.1523-1755.2002.00250.x","volume":"61","author":"T Ecder","year":"2002","unstructured":"Ecder T, Melnikov VY, Stanley M, Korular D, Lucia MS, Schrier RW, Edelstein CL (2002) Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int 61(4):1220\u20131230. doi: 10.1046\/j.1523-1755.2002.00250.x","journal-title":"Kidney Int"},{"issue":"4","key":"3_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495\u2013516. doi: 10.1080\/01926230701320337","journal-title":"Toxicol Pathol"},{"issue":"6835","key":"3_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411(6835):342\u2013348. doi: 10.1038\/35077213","journal-title":"Nature"},{"issue":"10","key":"3_CR11","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone 2nd","year":"2003","unstructured":"Gattone VH 2nd, Wang X, Harris PC, Torres VE (2003) Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9(10):1323\u20131326. doi: 10.1038\/nm935","journal-title":"Nat Med"},{"issue":"10","key":"3_CR12","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbadis.2011.01.006","volume":"1812","author":"B Goilav","year":"2011","unstructured":"Goilav B (2011) Apoptosis in polycystic kidney disease. Biochim Biophys Acta 1812(10):1272\u20131280. doi: 10.1016\/j.bbadis.2011.01.006","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3_CR13","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1073\/pnas.98.3.1182","volume":"98","author":"S Gonzalez-Perrett","year":"2001","unstructured":"Gonzalez-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF (2001) Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2 + -permeable nonselective cation channel. Proc Natl Acad Sci U S A 98(3):1182\u20131187","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321\u2013337. doi: 10.1146\/annurev.med.60.101707.125712","journal-title":"Annu Rev Med"},{"issue":"7","key":"3_CR15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4161\/cc.6.7.4047","volume":"6","author":"O Ibraghimov-Beskrovnaya","year":"2007","unstructured":"Ibraghimov-Beskrovnaya O (2007) Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy. Cell Cycle 6(7):776\u2013779","journal-title":"Cell Cycle"},{"issue":"11","key":"3_CR16","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.biochi.2013.07.030","volume":"95","author":"M Joshi","year":"2013","unstructured":"Joshi M, Kulkarni A, Pal JK (2013) Small molecule modulators of eukaryotic initiation factor 2alpha kinases, the key regulators of protein synthesis. Biochimie 95(11):1980\u20131990. doi: 10.1016\/j.biochi.2013.07.030","journal-title":"Biochimie"},{"issue":"6","key":"3_CR17","first-page":"1153","volume":"13","author":"J Lanoix","year":"1996","unstructured":"Lanoix J, D\u2019Agati V, Szabolcs M, Trudel M (1996) Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 13(6):1153\u20131160","journal-title":"Oncogene"},{"issue":"Pt 20","key":"3_CR18","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(Pt 20):3589\u20133594. doi: 10.1242\/jcs.051011","journal-title":"J Cell Sci"},{"issue":"4","key":"3_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.trsl.2014.11.003","volume":"165","author":"WB LaRiviere","year":"2015","unstructured":"LaRiviere WB, Irazabal MV, Torres VE (2015) Novel therapeutic approaches to autosomal dominant polycystic kidney disease. Transl Res J Lab Clin Med 165(4):488\u2013498. doi: 10.1016\/j.trsl.2014.11.003","journal-title":"Transl Res J Lab Clin Med"},{"issue":"50","key":"3_CR20","doi-asserted-by":"publisher","first-page":"41298","DOI":"10.1074\/jbc.M510082200","volume":"280","author":"Y Li","year":"2005","unstructured":"Li Y, Wright JM, Qian F, Germino GG, Guggino WB (2005) Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling. J Biol Chem 280(50):41298\u201341306. doi: 10.1074\/jbc.M510082200","journal-title":"J Biol Chem"},{"issue":"20","key":"3_CR21","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1093\/hmg\/ddn221","volume":"17","author":"G Liang","year":"2008","unstructured":"Liang G, Yang J, Wang Z, Li Q, Tang Y, Chen XZ (2008) Polycystin-2 down-regulates cell proliferation via promoting PERK-dependent phosphorylation of eIF2alpha. Hum Mol Genet 17(20):3254\u20133262. doi: 10.1093\/hmg\/ddn221","journal-title":"Hum Mol Genet"},{"issue":"8","key":"3_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.cub.2005.02.053","volume":"15","author":"X Long","year":"2005","unstructured":"Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005) Rheb binds and regulates the mTOR kinase. Curr Biol CB 15(8):702\u2013713. doi: 10.1016\/j.cub.2005.02.053","journal-title":"Curr Biol CB"},{"issue":"9","key":"3_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma M, Tian X, Igarashi P, Pazour GJ, Somlo S (2013) Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet 45(9):1004\u20131012. doi: 10.1038\/ng.2715","journal-title":"Nat Genet"},{"issue":"3","key":"3_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","volume":"132","author":"TV Masyuk","year":"2007","unstructured":"Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF (2007) Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3\u2032,5\u2032-cyclic monophosphate. Gastroenterology 132(3):1104\u20131116. doi: 10.1053\/j.gastro.2006.12.039","journal-title":"Gastroenterology"},{"issue":"1","key":"3_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/hep.26140","volume":"58","author":"TV Masyuk","year":"2013","unstructured":"Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Gradilone SA, Huang B, Masyuk AI, Hogan MC, Torres VE, Larusso NF (2013) Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. Hepatology 58(1):409\u2013421. doi: 10.1002\/hep.26140","journal-title":"Hepatology"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0074-7696(03)01004-0","volume":"226","author":"JM Mitchison","year":"2003","unstructured":"Mitchison JM (2003) Growth during the cell cycle. Int Rev Cytol 226:165\u2013258","journal-title":"Int Rev Cytol"},{"issue":"1","key":"3_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbamcr.2010.10.010","volume":"1813","author":"L Portt","year":"2011","unstructured":"Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT (2011) Anti-apoptosis and cell survival: a review. Biochim Biophys Acta 1813(1):238\u2013259. doi: 10.1016\/j.bbamcr.2010.10.010","journal-title":"Biochim Biophys Acta"},{"issue":"3-4","key":"3_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000368244","volume":"128","author":"C Riella","year":"2014","unstructured":"Riella C, Czarnecki PG, Steinman TI (2014) Therapeutic advances in the treatment of polycystic kidney disease. Nephron Clin Pract 128(3-4):297\u2013302. doi: 10.1159\/000368244","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"3_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","volume":"31","author":"I Ruvinsky","year":"2006","unstructured":"Ruvinsky I, Meyuhas O (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31(6):342\u2013348. doi: 10.1016\/j.tibs.2006.04.003","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"3_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1159\/000330080","volume":"27","author":"NG Santoso","year":"2011","unstructured":"Santoso NG, Cebotaru L, Guggino WB (2011) Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K\/Akt pathway. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 27(6):715\u2013726. doi: 10.1159\/000330080","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"issue":"1 Pt 2","key":"3_CR31","first-page":"F184","volume":"271","author":"CM Sorenson","year":"1996","unstructured":"Sorenson CM, Padanilam BJ, Hammerman MR (1996) Abnormal postpartum renal development and cystogenesis in the bcl-2 (-\/-) mouse. Am J Phys 271(1 Pt 2):F184\u2013F193","journal-title":"Am J Phys"},{"issue":"3","key":"3_CR32","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1523-1755.2005.00155.x","volume":"67","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Stanley M, He Z, Faubel S, Schrier RW, Edelstein CL (2005) Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD). Kidney Int 67(3):909\u2013919. doi: 10.1111\/j.1523-1755.2005.00155.x","journal-title":"Kidney Int"},{"issue":"4","key":"3_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH 2nd (2004) Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10(4):363\u2013364. doi: 10.1038\/nm1004","journal-title":"Nat Med"},{"issue":"2","key":"3_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","volume":"75","author":"DJ Veis","year":"1993","unstructured":"Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75(2):229\u2013240","journal-title":"Cell"},{"issue":"3","key":"3_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, Wuthrich RP (2006) Inhibition of mTOR with sirolimus slows disease progression in Han: SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 21(3):598\u2013604. doi: 10.1093\/ndt\/gfi181","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc"},{"issue":"4","key":"3_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang X, Gattone V 2nd, Harris PC, Torres VE (2005) Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol JASN 16(4):846\u2013851. doi: 10.1681\/ASN.2004121090","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"3_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1681\/ASN.2007060688","volume":"19","author":"X Wang","year":"2008","unstructured":"Wang X, Wu Y, Ward CJ, Harris PC, Torres VE (2008) Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol JASN 19(1):102\u2013108. doi: 10.1681\/ASN.2007060688","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"3_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ki.2009.438","volume":"77","author":"X Wang","year":"2010","unstructured":"Wang X, Ward CJ, Harris PC, Torres VE (2010) Cyclic nucleotide signaling in polycystic kidney disease. Kidney Int 77(2):129\u2013140. doi: 10.1038\/ki.2009.438","journal-title":"Kidney Int"},{"issue":"29","key":"3_CR39","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.1074\/jbc.274.29.20049","volume":"274","author":"BB Wolf","year":"1999","unstructured":"Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274(29):20049\u201320052","journal-title":"J Biol Chem"},{"issue":"1","key":"3_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM199507063330104","volume":"333","author":"D Woo","year":"1995","unstructured":"Woo D (1995) Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333(1):18\u201325. doi: 10.1056\/NEJM199507063330104","journal-title":"N Engl J Med"},{"issue":"6","key":"3_CR41","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","volume":"63","author":"T Yamaguchi","year":"2003","unstructured":"Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Pelling JC, Grantham JJ (2003) Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63(6):1983\u20131994. doi: 10.1046\/j.1523-1755.2003.00023.x","journal-title":"Kidney Int"},{"issue":"39","key":"3_CR42","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","volume":"279","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP (2004) Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279(39):40419\u201340430. doi: 10.1074\/jbc.M405079200","journal-title":"J Biol Chem"},{"issue":"1","key":"3_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12(1):9\u201318. doi: 10.1038\/sj.cr.7290105","journal-title":"Cell Res"},{"issue":"2","key":"3_CR44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00019606-199804000-00001","volume":"7","author":"XJ Zhou","year":"1998","unstructured":"Zhou XJ, Kukes G (1998) Pathogenesis of autosomal dominant polycystic kidney disease: role of apoptosis. Diagn Mol Pathol Am J Sur Pathol B 7(2):65\u201368","journal-title":"Diagn Mol Pathol Am J Sur Pathol B"}],"container-title":["Advances in Experimental Medicine and Biology","Cystogenesis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-2041-4_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:53:22Z","timestamp":1498337602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-2041-4_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9789811020407","9789811020414"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-2041-4_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}